← Portfolio Scout

Portfolio company

Yarrow Bioscience

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Digital Health

About

This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies